1. Home
  2. KNDI vs APLT Comparison

KNDI vs APLT Comparison

Compare KNDI & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNDI
  • APLT
  • Stock Information
  • Founded
  • KNDI 2002
  • APLT 2016
  • Country
  • KNDI China
  • APLT United States
  • Employees
  • KNDI N/A
  • APLT N/A
  • Industry
  • KNDI Auto Manufacturing
  • APLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • KNDI Consumer Discretionary
  • APLT Health Care
  • Exchange
  • KNDI Nasdaq
  • APLT Nasdaq
  • Market Cap
  • KNDI 91.2M
  • APLT 80.3M
  • IPO Year
  • KNDI N/A
  • APLT 2019
  • Fundamental
  • Price
  • KNDI $1.07
  • APLT $0.61
  • Analyst Decision
  • KNDI
  • APLT Buy
  • Analyst Count
  • KNDI 0
  • APLT 7
  • Target Price
  • KNDI N/A
  • APLT $6.10
  • AVG Volume (30 Days)
  • KNDI 118.9K
  • APLT 4.6M
  • Earning Date
  • KNDI 03-13-2025
  • APLT 03-05-2025
  • Dividend Yield
  • KNDI N/A
  • APLT N/A
  • EPS Growth
  • KNDI N/A
  • APLT N/A
  • EPS
  • KNDI N/A
  • APLT N/A
  • Revenue
  • KNDI $118,127,232.00
  • APLT N/A
  • Revenue This Year
  • KNDI N/A
  • APLT N/A
  • Revenue Next Year
  • KNDI N/A
  • APLT $2,622.90
  • P/E Ratio
  • KNDI N/A
  • APLT N/A
  • Revenue Growth
  • KNDI N/A
  • APLT N/A
  • 52 Week Low
  • KNDI $0.89
  • APLT $0.54
  • 52 Week High
  • KNDI $2.98
  • APLT $10.62
  • Technical
  • Relative Strength Index (RSI)
  • KNDI 47.38
  • APLT 27.09
  • Support Level
  • KNDI $1.03
  • APLT $0.54
  • Resistance Level
  • KNDI $1.12
  • APLT $0.64
  • Average True Range (ATR)
  • KNDI 0.06
  • APLT 0.07
  • MACD
  • KNDI -0.01
  • APLT 0.12
  • Stochastic Oscillator
  • KNDI 15.38
  • APLT 31.65

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in the development, production, and distribution of electric vehicle (EV) products, EV parts, and off-road vehicle products in the Chinese market. Other product offerings include all-terrain vehicles, go-karts, utility vehicles, battery packs, and other systems. It generates maximum revenue through off-road vehicles. The company generates the majority of its revenue from the United states along with other Countries, followed by China.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: